Related Experiment Video
Updated: Feb 9, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Rare genetic mutations in Pakistani patients with dilated cardiomyopathy
Muhammad Shakeel1, Muhammad Irfan1, Ishtiaq Ahmad Khan1
1Jamil-ur-Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Insights
Genetic factors contribute to dilated cardiomyopathy (DCM), a heart failure cause. Whole exome sequencing identified detrimental variants in cardiac genes, including MYOM3, offering potential for DCM risk assessment and precision therapy.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genomics
Background:
- Dilated cardiomyopathy (DCM) is a primary cause of heart failure and necessitates heart transplantation.
- Genetic factors are implicated in up to 50% of DCM cases, yet its complex pathophysiology remains incompletely understood.
- Idiopathic DCM presents a significant challenge due to its heterogeneity and unclear underlying mechanisms.
Purpose of the Study:
- To identify genetic variants associated with idiopathic DCM through whole exome sequencing.
- To investigate the role of rare deleterious variants in cardiac-expressed genes in DCM pathogenesis.
- To explore potential genetic markers for risk assessment and targeted therapies in DCM.
Main Methods:
- Whole exome sequencing of five unrelated idiopathic DCM patients to an average depth of 100×.
- In silico analysis using SIFT, Polyphen2, and CADD to predict the deleteriousness of single nucleotide variants (SNVs).
- Analysis of allele frequencies and linkage disequilibrium to identify potentially pathogenic variants and their association with DCM.
Main Results:
- Sequencing identified 494 rare missense SNVs predicted as deleterious.
- Loss-of-function variants in C2orf40, MYOM3, and TMED4, a frameshift insertion in RTKN2, and a splice site deletion in SLC6A6 were found.
- A stop-gained variant in MYOM3 (rs143187236) was in perfect linkage disequilibrium with a neighboring missense variant, highlighting MYOM3's role.
- Variants rs375563861 (C2orf40), rs143187236 (MYOM3), and rs564181443 (RTKN2) showed significantly higher allele frequencies in South Asians.
Conclusions:
- Whole exome sequencing revealed multiple rare, deleterious variants in genes critical for cardiac function in idiopathic DCM patients.
- Specific variants in MYOM3, C2orf40, and RTKN2 may play a significant role in DCM pathophysiology, particularly in South Asian populations.
- These identified pathogenic variants hold promise for improving risk stratification and enabling precision medicine approaches for DCM management.
Abstract:
Dilated cardiomyopathy (DCM) is a leading cause of heart failure, and heart transplantation globally. There is enlargement of left ventricle of the heart impairing the systolic function in this disorder. The involvement of genetic factors in the pathogenesis of DCM has been reported in up to 50% of the cases. However, due to the complexity and heterogeneity of the disease, the complete pathophysiology remains unclear. In this study, whole exomes of five unrelated patients of idiopathic DCM were sequenced to an average depth of 100× using Illumina HiSeq4000 system. The analysis of the data with in silico tools SIFT, Polyphen2, and CADD showed 494 rare (AF < 1.0%) missense SNVs predicted as deleterious. Detrimental variants in genes highly expressed in cardiac tissue included 3 rare allele frequency loss-of-function SNVs in C2orf40, MYOM3, and TMED4 genes, a homozygous frameshift insertion in RTKN2, and a splice site homozygous deletion in SLC6A6 in at least one of the patients. The stop-gained SNV rs143187236 of MYOM3 (myomesin 3) was found in perfect linkage disequilibrium (r2 = 1.0) with its neighboring missense SNV rs149105212 in two of the patients, representing the role of myomesin 3 in pathophysiology of DCM. Allele frequency comparison showed three variants rs375563861 (C2orf40), rs143187236 (MYOM3), and rs564181443 (RTKN2) having 3 fold or higher allele frequency in South Asians than in the global populations. The identified pathogenic variants can be used in risk assessment and precision therapy in DCM patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Mutation, Gene Flow, and Genetic Drift
Mutations
Viral Mutations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

